Total Payments
$1,567
2024 Payments
$547.47
Companies
19
Transactions
95
Medicare Patients
5,015
Medicare Billing
$407,182
Payment Breakdown by Category
Food & Beverage$1,480 (94.5%)
Education$86.84 (5.5%)
Other$0.00 (0.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,480 | 93 | 94.5% |
| Education | $86.84 | 2 | 5.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Regeneron Healthcare Solutions, Inc. | $211.84 | 9 | $0 (2024) |
| ABBVIE INC. | $206.22 | 18 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $198.99 | 12 | $0 (2024) |
| Janssen Biotech, Inc. | $177.13 | 5 | $0 (2024) |
| MAYNE PHARMA COMMERCIAL LLC | $152.55 | 10 | $0 (2024) |
| Lilly USA, LLC | $130.18 | 8 | $0 (2024) |
| GENZYME CORPORATION | $108.89 | 7 | $0 (2024) |
| PFIZER INC. | $86.74 | 6 | $0 (2024) |
| Arcutis Biotherapeutics, Inc. | $70.92 | 5 | $0 (2024) |
| Galderma Laboratories, L.P. | $45.13 | 3 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $547.47 | 38 | ABBVIE INC. ($136.58) |
| 2023 | $754.98 | 38 | Regeneron Healthcare Solutions, Inc. ($181.80) |
| 2022 | $236.43 | 17 | PFIZER INC. ($43.47) |
| 2021 | $28.30 | 2 | AbbVie Inc. ($14.82) |
All Payment Transactions
95 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $16.47 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Education | In-kind items and services | $8.45 | General |
| Category: IMMUNOLOGY | ||||||
| 12/03/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.54 | General |
| Category: IMMUNOLOGY | ||||||
| 11/25/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $16.68 | General |
| Category: Immunology | ||||||
| 11/18/2024 | Amgen Inc. | Otezla (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Inflammation | ||||||
| 11/11/2024 | PFIZER INC. | EUCRISA (Drug), CIBINQO, LITFULO | Food and Beverage | In-kind items and services | $14.39 | General |
| Category: DERMATOLOGY | ||||||
| 10/29/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $13.49 | General |
| Category: Immunology | ||||||
| 10/28/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $19.48 | General |
| Category: Dermatology | ||||||
| 10/21/2024 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $13.95 | General |
| Category: DERMATOLOGY | ||||||
| 10/17/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.41 | General |
| Category: IMMUNOLOGY | ||||||
| 10/14/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $14.37 | General |
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.15 | General |
| Category: IMMUNOLOGY | ||||||
| 10/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $12.22 | General |
| Category: IMMUNOLOGY | ||||||
| 10/07/2024 | Galderma Laboratories, L.P. | — | Food and Beverage | In-kind items and services | $15.12 | General |
| 09/24/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $10.47 | General |
| Category: IMMUNOLOGY | ||||||
| 09/23/2024 | Regeneron Healthcare Solutions, Inc. | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $15.63 | General |
| Category: INFLAMMATION AND IMMUNOLOGY | ||||||
| 09/16/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $14.52 | General |
| Category: Immunology | ||||||
| 09/13/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $8.29 | General |
| Category: IMMUNOLOGY | ||||||
| 09/09/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: Dermatology | ||||||
| 09/05/2024 | Verrica Pharmaceuticals Inc. | YCANTH (Drug) | Food and Beverage | In-kind items and services | $16.87 | General |
| Category: DERMATOLOGY | ||||||
| 08/16/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $6.16 | General |
| Category: IMMUNOLOGY | ||||||
| 08/06/2024 | GENZYME CORPORATION | DUPIXENT (Biological) | Food and Beverage | In-kind items and services | $14.92 | General |
| Category: Immunology | ||||||
| 07/26/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $9.16 | General |
| Category: IMMUNOLOGY | ||||||
| 07/22/2024 | Lilly USA, LLC | TALTZ (Drug) | Food and Beverage | In-kind items and services | $15.96 | General |
| Category: Immunology | ||||||
| 07/16/2024 | MAYNE PHARMA COMMERCIAL LLC | — | Food and Beverage | In-kind items and services | $16.82 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 12 | 1,166 | 3,244 | $503,565 | $96,528 |
| 2022 | 15 | 1,496 | 3,517 | $577,440 | $114,383 |
| 2021 | 13 | 1,358 | 2,889 | $397,884 | $115,955 |
| 2020 | 11 | 995 | 2,046 | $233,529 | $80,316 |
Total Patients
5,015
Total Services
11,696
Medicare Billing
$407,182
Procedure Codes
51
All Medicare Procedures & Services
51 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 283 | 462 | $90,090 | $26,346 | 29.2% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2023 | 201 | 287 | $100,450 | $19,698 | 19.6% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 177 | 347 | $104,100 | $11,638 | 11.2% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2023 | 107 | 243 | $42,525 | $8,957 | 21.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 65 | 92 | $20,700 | $7,607 | 36.8% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 132 | 1,584 | $79,200 | $7,564 | 9.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 97 | 97 | $24,250 | $5,711 | 23.6% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2023 | 21 | 34 | $17,000 | $2,671 | 15.7% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 18 | 18 | $5,850 | $2,037 | 34.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2023 | 13 | 16 | $6,000 | $1,866 | 31.1% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 38 | 45 | $6,750 | $1,535 | 22.7% |
| 69100 | Biopsy of ear | Office | 2023 | 14 | 19 | $6,650 | $897.63 | 13.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 317 | 483 | $94,185 | $25,989 | 27.6% |
| 11102 | Biopsy of related skin growth, first growth | Office | 2022 | 261 | 346 | $121,100 | $23,851 | 19.7% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2022 | 221 | 385 | $115,500 | $13,505 | 11.7% |
| 11103 | Biopsy of related skin growth, each additional growth | Office | 2022 | 144 | 318 | $55,650 | $11,999 | 21.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 94 | 125 | $28,125 | $9,906 | 35.2% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 120 | 120 | $30,000 | $7,923 | 26.4% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2022 | 184 | 1,528 | $76,400 | $7,523 | 9.8% |
| 17004 | Destruction of precancer skin growth, 15 or more growths | Office | 2022 | 34 | 46 | $17,250 | $5,396 | 31.3% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 25 | 25 | $8,125 | $2,743 | 33.8% |
| 17110 | Destruction of skin growth, 1-14 growths | Office | 2022 | 16 | 26 | $13,000 | $1,927 | 14.8% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2022 | 32 | 33 | $4,950 | $1,262 | 25.5% |
| 11104 | Punch biopsy, first skin growth | Office | 2022 | 11 | 11 | $3,850 | $1,081 | 28.1% |
| 11900 | Injection into skin growth, 1-7 growths | Office | 2022 | 13 | 21 | $4,725 | $663.52 | 14.0% |
About Brittany Davis
Brittany Davis is a Medical healthcare provider based in Elmer, New Jersey. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/29/2014. The National Provider Identifier (NPI) number assigned to this provider is 1801291109.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brittany Davis has received a total of $1,567 in payments from pharmaceutical and medical device companies, with $547.47 received in 2024. These payments were reported across 95 transactions from 19 companies. The most common payment nature is "Food and Beverage" ($1,480).
As a Medicare-enrolled provider, Davis has provided services to 5,015 Medicare beneficiaries, totaling 11,696 services with total Medicare billing of $407,182. Data is available for 4 years (2020–2023), covering 51 distinct procedure/service records.
Ad
Practice Information
- Specialty Medical
- Other Specialties Medical
- Location Elmer, NJ
- Active Since 10/29/2014
- Last Updated 01/17/2017
- Taxonomy Code 363AM0700X
- Entity Type Individual
- NPI Number 1801291109
Products in Payments
- DUPIXENT (Biological) $320.73
- SKYRIZI (Biological) $175.38
- TREMFYA (Drug) $163.22
- COSENTYX (Drug) $157.55
- TALTZ (Drug) $130.18
- EUCRISA (Drug) $86.74
- COSENTYX (Biological) $41.44
- Otezla (Drug) $34.69
- OPZELURA (Drug) $30.97
- RINVOQ (Biological) $30.84
- YCANTH (Drug) $16.87
- Zoryve (Drug) $16.36
- AKLIEF (Drug) $15.45
- Winlevi (Drug) $15.16
- EPSOLAY (Drug) $14.56
- ADBRY (Biological) $14.33
- VTAMA (Drug) $13.95
- REMICADE (Biological) $13.91
- ARAZLO (Drug) $13.48
- Cimzia (Drug) $13.06
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.